FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095445452> ?p ?o ?g. }

• W2095445452 endingPage "54" @default.
• W2095445452 startingPage "48" @default.
• W2095445452 abstract "OBJECTIVE To describe the preliminary results of the Dutch section of a large multicentre study of screening for prostate cancer, the European Randomized study of Screening for Prostate Cancer (ERSPC), initiated in the Netherlands and Belgium in 1991. MATERIALS AND METHODS After a series of five pilot studies which started in 1991, full‐capacity screening started in 1994 with the use of a serum prostate‐specific antigen (PSA) determination, a digital rectal examination (DRE) and transrectal ultrasonography (TRUS) as screening tests. Depending on the results and the screening protocol used, men were referred for further examination by sextant biopsies (extended with a seventh biopsy if TRUS showed abnormality). The protocols used, efficiency of the different screening tests, number of cancers detected in the pilot studies, initial screening round and preliminary results of the second screening round are described. RESULTS After the pilot studies it became clear that a study of prostate cancer screening was feasible in the Rotterdam area. The screening protocol was workable and the recruitment rate acceptable (39.5%). An inventory of the population registries of Rotterdam and surrounding municipalities, and the known recruitment rate, made it clear that a contribution of 40 000 men (aged 55–74 years) from the Dutch centre to the ERSPC was feasible. The initial screening round started in December 1993 and lasted until December 1999 (protocol 5–10). In all, 42 376 men were randomized and 1014 cancers detected (5.1%). During this screening the protocol was simplified. After evaluating the different screening tests abnormal results of the DRE and TRUS were omitted as an indication for a sextant biopsy. Only a serum PSA level of ≥ 3.0 ng/mL is now used as the indication. The second screening round started in December 1997 and continues. To December 2002, 9920 men were screened for the second time, 4 years after their initial screening visit. To date 446 cancers have been detected (4.5%); this round will last to December 2003. Further evaluation of the screening regimen and characteristics of the cancers detected are constantly assessed within the Dutch ERSPC. Meanwhile a third screening round has also been initiated, which will last to December 2007. CONCLUSION A prostate cancer screening study of the projected magnitude is feasible in Rotterdam; the recruitment rate is acceptable and the screening tests well tolerated. The study has generated many scientific publications and will be of great value in determining whether prostate cancer screening should be part of general healthcare." @default.
• W2095445452 created "2016-06-24" @default.
• W2095445452 creator A5039867286 @default.
• W2095445452 creator A5041240078 @default.
• W2095445452 creator A5049762337 @default.
• W2095445452 date "2003-12-01" @default.
• W2095445452 modified "2023-10-18" @default.
• W2095445452 title "Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands)" @default.
• W2095445452 cites W157096457 @default.
• W2095445452 cites W1966144486 @default.
• W2095445452 cites W1976352730 @default.
• W2095445452 cites W1986361260 @default.
• W2095445452 cites W1989304309 @default.
• W2095445452 cites W2016995945 @default.
• W2095445452 cites W2023232494 @default.
• W2095445452 cites W2024053741 @default.
• W2095445452 cites W2031075531 @default.
• W2095445452 cites W2032209162 @default.
• W2095445452 cites W2044234706 @default.
• W2095445452 cites W2054128532 @default.
• W2095445452 cites W2057469006 @default.
• W2095445452 cites W2088264797 @default.
• W2095445452 cites W2115439764 @default.
• W2095445452 cites W2142775721 @default.
• W2095445452 cites W2144521425 @default.
• W2095445452 cites W2335679869 @default.
• W2095445452 cites W2461412995 @default.
• W2095445452 cites W4320801182 @default.
• W2095445452 doi "https://doi.org/10.1111/j.1464-410x.2003.04390.x" @default.
• W2095445452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14983955" @default.
• W2095445452 hasPublicationYear "2003" @default.
• W2095445452 type Work @default.
• W2095445452 sameAs 2095445452 @default.
• W2095445452 citedByCount "95" @default.
• W2095445452 countsByYear W20954454522012 @default.
• W2095445452 countsByYear W20954454522013 @default.
• W2095445452 countsByYear W20954454522014 @default.
• W2095445452 countsByYear W20954454522015 @default.
• W2095445452 countsByYear W20954454522016 @default.
• W2095445452 countsByYear W20954454522017 @default.
• W2095445452 countsByYear W20954454522018 @default.
• W2095445452 countsByYear W20954454522019 @default.
• W2095445452 countsByYear W20954454522022 @default.
• W2095445452 countsByYear W20954454522023 @default.
• W2095445452 crossrefType "journal-article" @default.
• W2095445452 hasAuthorship W2095445452A5039867286 @default.
• W2095445452 hasAuthorship W2095445452A5041240078 @default.
• W2095445452 hasAuthorship W2095445452A5049762337 @default.
• W2095445452 hasConcept C121608353 @default.
• W2095445452 hasConcept C126322002 @default.
• W2095445452 hasConcept C141071460 @default.
• W2095445452 hasConcept C168563851 @default.
• W2095445452 hasConcept C2775941076 @default.
• W2095445452 hasConcept C2780002838 @default.
• W2095445452 hasConcept C2780101318 @default.
• W2095445452 hasConcept C2780192828 @default.
• W2095445452 hasConcept C2781406297 @default.
• W2095445452 hasConcept C2908647359 @default.
• W2095445452 hasConcept C29456083 @default.
• W2095445452 hasConcept C71924100 @default.
• W2095445452 hasConcept C99454951 @default.
• W2095445452 hasConceptScore W2095445452C121608353 @default.
• W2095445452 hasConceptScore W2095445452C126322002 @default.
• W2095445452 hasConceptScore W2095445452C141071460 @default.
• W2095445452 hasConceptScore W2095445452C168563851 @default.
• W2095445452 hasConceptScore W2095445452C2775941076 @default.
• W2095445452 hasConceptScore W2095445452C2780002838 @default.
• W2095445452 hasConceptScore W2095445452C2780101318 @default.
• W2095445452 hasConceptScore W2095445452C2780192828 @default.
• W2095445452 hasConceptScore W2095445452C2781406297 @default.
• W2095445452 hasConceptScore W2095445452C2908647359 @default.
• W2095445452 hasConceptScore W2095445452C29456083 @default.
• W2095445452 hasConceptScore W2095445452C71924100 @default.
• W2095445452 hasConceptScore W2095445452C99454951 @default.
• W2095445452 hasIssue "s2" @default.
• W2095445452 hasLocation W20954454521 @default.
• W2095445452 hasLocation W20954454522 @default.
• W2095445452 hasOpenAccess W2095445452 @default.
• W2095445452 hasPrimaryLocation W20954454521 @default.
• W2095445452 hasRelatedWork W2026031023 @default.
• W2095445452 hasRelatedWork W2027152138 @default.
• W2095445452 hasRelatedWork W2027692008 @default.
• W2095445452 hasRelatedWork W2047550847 @default.
• W2095445452 hasRelatedWork W2061764103 @default.
• W2095445452 hasRelatedWork W2077734404 @default.
• W2095445452 hasRelatedWork W2364265485 @default.
• W2095445452 hasRelatedWork W2423353577 @default.
• W2095445452 hasRelatedWork W65565690 @default.
• W2095445452 hasRelatedWork W2527018723 @default.
• W2095445452 hasVolume "92" @default.
• W2095445452 isParatext "false" @default.
• W2095445452 isRetracted "false" @default.
• W2095445452 magId "2095445452" @default.
• W2095445452 workType "article" @default.